Baran D T, Ray R, Sorensen A M, Honeyman T, Holick M F
Department of Orthopedics, University of Massachusetts Medical Center, Worcester 01655.
J Cell Biochem. 1994 Dec;56(4):510-7. doi: 10.1002/jcb.240560411.
The steroid hormone 1 alpha,25-dihydroxyvitamin D3 has been shown to exert rapid effects (15 s to 5 min) in osteoblasts. These effects occur in osteoblast-like cells lacking the nuclear vitamin D receptor, ROS 24/1, suggesting that a separate signalling system mediates the rapid actions. These non-genomic actions include rapid activation of phospholipase C and opening of calcium channels, pointing to a membrane localization of this signalling system. Previous studies have shown that the 1 beta epimer of 1 alpha,25-dihydroxyvitamin D3 can block these rapid actions, indicating that the 1 beta epimer may bind to the receptor responsible for the rapid actions in a competitive manner. We have assessed the displacement of 3H-1 alpha,25-dihydroxyvitamin D3 by vitamin D compounds, as well as the apparent dissociation constant of 1 alpha,25-dihydroxyvitamin D3 and its 1 beta epimer for the membrane receptor in membrane preparations from ROS 24/1 cells. Increasing concentrations of 1 alpha,25-dihydroxyvitamin D3, 7.25 nM to 725 nM, displaced 3H-1 alpha,25-dihydroxyvitamin D3 from the membranes with 725 nM of the hormone displacing 40-49% of the radioactivity. Similarly, 1 beta,25-dihydroxyvitamin D3, 7.25 nM and 72.5 nM, displaced 1 alpha,25-dihydroxyvitamin D3 binding while 25-hydroxyvitamin D3, 72.5 nM and 725 nM, did not. The apparent dissociation constant (KD) for 1 alpha,25-dihydroxyvitamin D3 was determined from displacement of 3H-1 alpha,25-dihydroxyvitamin D3 yielding a value of 8.1 x 10(-7) M by Scatchard analysis. The KD for the 1 beta epimer determined from displacement of 3H-1 beta,25-dihydroxyvitamin D3 was 4.8 x 10(-7) M.(ABSTRACT TRUNCATED AT 250 WORDS)
类固醇激素1α,25 - 二羟基维生素D3已被证明可在成骨细胞中发挥快速作用(15秒至5分钟)。这些作用发生在缺乏核维生素D受体的成骨样细胞ROS 24/1中,这表明存在一个独立的信号系统介导这些快速作用。这些非基因组作用包括磷脂酶C的快速激活和钙通道的开放,表明该信号系统定位于细胞膜。先前的研究表明,1α,25 - 二羟基维生素D3的1β差向异构体可阻断这些快速作用,这表明1β差向异构体可能以竞争性方式与负责快速作用的受体结合。我们评估了维生素D化合物对3H - 1α,25 - 二羟基维生素D3的置换情况,以及1α,25 - 二羟基维生素D3及其1β差向异构体对ROS 24/1细胞膜制剂中膜受体的表观解离常数。1α,25 - 二羟基维生素D3浓度从7.25 nM增加到725 nM时,可将3H - 1α,25 - 二羟基维生素D3从细胞膜上置换下来,725 nM的该激素可置换40 - 49%的放射性。同样,1β,25 - 二羟基维生素D3(7.25 nM和72.5 nM)可置换1α,25 - 二羟基维生素D3的结合,而25 - 羟基维生素D3(72.5 nM和725 nM)则不能。通过Scatchard分析,由3H - 1α,25 - 二羟基维生素D3的置换情况确定1α,25 - 二羟基维生素D3的表观解离常数(KD)为8.1×10^(-7) M。由3H - 1β,25 - 二羟基维生素D3的置换情况确定1β差向异构体的KD为4.8×10^(-7) M。(摘要截短于250字)